Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The aim of the present study was to investigate, in human lung cancer, the relationship between weight loss and the existence of a low body cell mass (BCM) on the one hand, and the putative presence of systemic inflammation, an increased acute-phase response, anorexia, hypermetabolism and changes in circulating levels of several anabolic and catabolic hormones on the other. In 20 male lung cancer patients, pre-stratified by weight loss of ⩾ 10% (n = 10) or of < 10% (n = 10), the following measurements were performed: BCM (by dual-energy X-ray absorptiometry/bromide dilution), circulating levels of sTNF-R55 and sTNF-R75 (soluble tumour necrosis factor receptors of molecular masses 55 and 75 kDa respectively), interleukin-6, lipopolysaccharide-binding protein, albumin, appetite (scale of 0–10), resting energy expenditure (by indirect calorimetry) and circulating levels of catabolic (cortisol) and anabolic [testosterone, insulin-like growth factor-I (IGF-I)] hormones. Compared with the patients with a weight loss of < 10%, those with a weight loss of ⩾ 10% were characterized by higher levels of sTNF-R55 (trend towards significance; P = 0.06), and lower levels of albumin (27.4 compared with 34.4 mmol/l; P = 0.02), testosterone (13.2 compared with 21.5 nmol/l; P = 0.01) and IGF-I (119 compared with 184 ng/ml; P = 0.004). In the patient group as a whole, the percentage weight loss was significantly correlated with sTNF-R55 (r = 0.59, P = 0.02), albumin (r =-0.63, P = 0.006) and IGF-I (r =-0.50, P = 0.02) levels. Height-adjusted BCM was significantly correlated with sTNF-R55 (r =-0.57, P = 0.03), sTNF-R75 (r =-0.50, P = 0.04), lipopolysaccharide-binding protein (r =-0.50, P = 0.04), albumin (r = 0.56, P = 0.02) and resting energy expenditure/BCM (r =-0.54, P = 0.03), and there was a trend towards a correlation with IGF-I concentration (r = 0.44, P = 0.06). We conclude that, in human lung cancer, weight loss and the presence of a low BCM are associated with systemic inflammation, an increased acute-phase response and decreased levels of IGF-I. In addition, a decreased BCM is associated with hypermetabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118398 · Cited by 421
BAMBINO, T. H., & HSUEH, A. J. W. (1981) · Endocrinology · doi:10.1210/endo-108-6-2142 · Cited by 360
Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range.
Simmons, P. S., Miles, J. M., Gerich, J. E., & Haymond, M. W. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111227 · Cited by 286
Cited by
Gupta, D., & Lis, C. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-69 · Cited by 1,485
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
Arends, J., Bodoky, G., Bozzetti, F., Fearon, K., Muscaritoli, M., Selga, G., van Bokhorst-de van der Schueren, M. A. E., von Meyenfeldt, M., Zürcher, G., Fietkau, R., et al. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.01.020 · Cited by 930
Stenvinkel, P., Heimbürger, O., Lindholm, B., Kaysen, G. A., & Bergström, J. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.7.953 · Cited by 811
Forrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., & Dunlop, D. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601242 · Cited by 792
Cancer‐related fatigue: Evolving concepts in evaluation and treatment
Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E., & Amadori, S. (2003) · Cancer · doi:10.1002/cncr.11742 · Cited by 712
Metadata
- Authors
- SIMONS, J. P. F. H. A., SCHOLS, A. M. W. J., BUURMAN, W. A., & WOUTERS, E. F. M.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 1999-06-28
- Volume
- 97
- Issue
- 2
- Pages
- 215-223
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2067419231
- Cited by
- 156
- References
- 3
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.